These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31379917)

  • 1. Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal Adenocarcinoma.
    Mishra NK; Southekal S; Guda C
    Front Genet; 2019; 10():624. PubMed ID: 31379917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Curia MC; Fantini F; Lattanzio R; Tavano F; Di Mola F; Piantelli M; Battista P; Di Sebastiano P; Cama A
    BMC Cancer; 2019 May; 19(1):452. PubMed ID: 31088413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylome in pancreatic cancer identified novel promoter hyper-methylation in NPY and FAIM2 genes associated with poor prognosis in Indian patient cohort.
    Chatterjee A; Bararia A; Ganguly D; Mondal PK; Roy P; Banerjee S; Ghosh S; Gulati S; Ghatak S; Chattopadhay BK; Basu P; Chatterjee A; Sikdar N
    Cancer Cell Int; 2022 Nov; 22(1):334. PubMed ID: 36329447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics analysis of intra-tumoural and inter-tumoural heterogeneity in pancreatic ductal adenocarcinoma.
    Liu X; Wang W; Liu X; Zhang Z; Yu L; Li R; Guo D; Cai W; Quan X; Wu H; Dai M; Liang Z
    Clin Transl Med; 2022 Jan; 12(1):e670. PubMed ID: 35061935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis.
    Rajamani D; Bhasin MK
    Genome Med; 2016 May; 8(1):38. PubMed ID: 27137215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling.
    Nones K; Waddell N; Song S; Patch AM; Miller D; Johns A; Wu J; Kassahn KS; Wood D; Bailey P; Fink L; Manning S; Christ AN; Nourse C; Kazakoff S; Taylor D; Leonard C; Chang DK; Jones MD; Thomas M; Watson C; Pinese M; Cowley M; Rooman I; Pajic M; ; Butturini G; Malpaga A; Corbo V; Crippa S; Falconi M; Zamboni G; Castelli P; Lawlor RT; Gill AJ; Scarpa A; Pearson JV; Biankin AV; Grimmond SM
    Int J Cancer; 2014 Sep; 135(5):1110-8. PubMed ID: 24500968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.
    Hanoun N; Delpu Y; Suriawinata AA; Bournet B; Bureau C; Selves J; Tsongalis GJ; Dufresne M; Buscail L; Cordelier P; Torrisani J
    Clin Chem; 2010 Jul; 56(7):1107-18. PubMed ID: 20431052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium Signaling Alterations Caused by Epigenetic Mechanisms in Pancreatic Cancer: From Early Markers to Prognostic Impact.
    Gregório C; Soares-Lima SC; Alemar B; Recamonde-Mendoza M; Camuzi D; de Souza-Santos PT; Rivero R; Machado S; Osvaldt A; Ashton-Prolla P; Pinto LFR
    Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32629766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Analysis of Cell-Free DNA Methylation Profiling for the Early Diagnosis of Pancreatic Cancer.
    Li S; Wang L; Zhao Q; Wang Z; Lu S; Kang Y; Jin G; Tian J
    Front Genet; 2020; 11():596078. PubMed ID: 33424927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions.
    Hernandez YG; Lucas AL
    World J Gastrointest Oncol; 2016 Jan; 8(1):18-29. PubMed ID: 26798434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsupervised subtyping and methylation landscape of pancreatic ductal adenocarcinoma.
    Roy S; Singh AP; Gupta D
    Heliyon; 2021 Jan; 7(1):e06000. PubMed ID: 33521362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
    Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
    JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic cancer survival analysis defines a signature that predicts outcome.
    Raman P; Maddipati R; Lim KH; Tozeren A
    PLoS One; 2018; 13(8):e0201751. PubMed ID: 30092011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Methylation-driven Genes in Pancreatic Ductal Adenocarcinoma for Predicting Prognosis.
    Zhang Z; Zhu R; Sun W; Wang J; Liu J
    J Cancer; 2021; 12(21):6507-6518. PubMed ID: 34659542
    [No Abstract]   [Full Text] [Related]  

  • 15. Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma.
    Li Q; Wang H; Zogopoulos G; Shao Q; Dong K; Lv F; Nwilati K; Gui XY; Cuggia A; Liu JL; Gao ZH
    Oncotarget; 2016 Nov; 7(47):77838-77853. PubMed ID: 27788482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2016 Aug; 39(4):379-88. PubMed ID: 27240826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Integrated Meta-Analysis of Secretome and Proteome Identify Potential Biomarkers of Pancreatic Ductal Adenocarcinoma.
    de Oliveira G; Freire PP; Cury SS; de Moraes D; Oliveira JS; Dal-Pai-Silva M; Reis PP; Carvalho RF
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32197468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.
    Dutruel C; Bergmann F; Rooman I; Zucknick M; Weichenhan D; Geiselhart L; Kaffenberger T; Rachakonda PS; Bauer A; Giese N; Hong C; Xie H; Costello JF; Hoheisel J; Kumar R; Rehli M; Schirmacher P; Werner J; Plass C; Popanda O; Schmezer P
    Oncogene; 2014 Jun; 33(26):3401-10. PubMed ID: 23912455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of long non-coding RNA LOC285194 and its prognostic significance in human pancreatic ductal adenocarcinoma.
    Ding YC; Yu W; Ma C; Wang Q; Huang CS; Huang T
    Int J Clin Exp Pathol; 2014; 7(11):8065-70. PubMed ID: 25550852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.